PROCESS FOR PRODUCING ROSUVASTATIN SALT
The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial sca...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; hun |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BARTHA FERENC KIRALY IMRE NAGY KALMAN DR MEZEI TIBOR DR RUZSICS GYOERGY BARKOCZY JOZSEF VOLK BALAZS KARASZ ADRIENN TOEMPE PETER DR SIMIG GYULA DR VAGO PAL DR |
description | The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial scale in high purity. The compound of the Formula (I) can be used for the treatment of diseases related to lipid metabolism. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUP0700667A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUP0700667A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUP0700667A23</originalsourceid><addsrcrecordid>eNrjZFAPCPJ3dg0OVnDzD1IAsl1CnT393BWC_INDwxyDQxxDPP0Ugh19QngYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSbxHaICBuYGBmZm5o5ExMWoAErkkdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROCESS FOR PRODUCING ROSUVASTATIN SALT</title><source>esp@cenet</source><creator>BARTHA FERENC ; KIRALY IMRE ; NAGY KALMAN DR ; MEZEI TIBOR DR ; RUZSICS GYOERGY ; BARKOCZY JOZSEF ; VOLK BALAZS ; KARASZ ADRIENN ; TOEMPE PETER DR ; SIMIG GYULA DR ; VAGO PAL DR</creator><creatorcontrib>BARTHA FERENC ; KIRALY IMRE ; NAGY KALMAN DR ; MEZEI TIBOR DR ; RUZSICS GYOERGY ; BARKOCZY JOZSEF ; VOLK BALAZS ; KARASZ ADRIENN ; TOEMPE PETER DR ; SIMIG GYULA DR ; VAGO PAL DR</creatorcontrib><description>The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial scale in high purity. The compound of the Formula (I) can be used for the treatment of diseases related to lipid metabolism.</description><language>eng ; hun</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090528&DB=EPODOC&CC=HU&NR=P0700667A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090528&DB=EPODOC&CC=HU&NR=P0700667A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BARTHA FERENC</creatorcontrib><creatorcontrib>KIRALY IMRE</creatorcontrib><creatorcontrib>NAGY KALMAN DR</creatorcontrib><creatorcontrib>MEZEI TIBOR DR</creatorcontrib><creatorcontrib>RUZSICS GYOERGY</creatorcontrib><creatorcontrib>BARKOCZY JOZSEF</creatorcontrib><creatorcontrib>VOLK BALAZS</creatorcontrib><creatorcontrib>KARASZ ADRIENN</creatorcontrib><creatorcontrib>TOEMPE PETER DR</creatorcontrib><creatorcontrib>SIMIG GYULA DR</creatorcontrib><creatorcontrib>VAGO PAL DR</creatorcontrib><title>PROCESS FOR PRODUCING ROSUVASTATIN SALT</title><description>The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial scale in high purity. The compound of the Formula (I) can be used for the treatment of diseases related to lipid metabolism.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAPCPJ3dg0OVnDzD1IAsl1CnT393BWC_INDwxyDQxxDPP0Ugh19QngYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSbxHaICBuYGBmZm5o5ExMWoAErkkdg</recordid><startdate>20090528</startdate><enddate>20090528</enddate><creator>BARTHA FERENC</creator><creator>KIRALY IMRE</creator><creator>NAGY KALMAN DR</creator><creator>MEZEI TIBOR DR</creator><creator>RUZSICS GYOERGY</creator><creator>BARKOCZY JOZSEF</creator><creator>VOLK BALAZS</creator><creator>KARASZ ADRIENN</creator><creator>TOEMPE PETER DR</creator><creator>SIMIG GYULA DR</creator><creator>VAGO PAL DR</creator><scope>EVB</scope></search><sort><creationdate>20090528</creationdate><title>PROCESS FOR PRODUCING ROSUVASTATIN SALT</title><author>BARTHA FERENC ; KIRALY IMRE ; NAGY KALMAN DR ; MEZEI TIBOR DR ; RUZSICS GYOERGY ; BARKOCZY JOZSEF ; VOLK BALAZS ; KARASZ ADRIENN ; TOEMPE PETER DR ; SIMIG GYULA DR ; VAGO PAL DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUP0700667A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>BARTHA FERENC</creatorcontrib><creatorcontrib>KIRALY IMRE</creatorcontrib><creatorcontrib>NAGY KALMAN DR</creatorcontrib><creatorcontrib>MEZEI TIBOR DR</creatorcontrib><creatorcontrib>RUZSICS GYOERGY</creatorcontrib><creatorcontrib>BARKOCZY JOZSEF</creatorcontrib><creatorcontrib>VOLK BALAZS</creatorcontrib><creatorcontrib>KARASZ ADRIENN</creatorcontrib><creatorcontrib>TOEMPE PETER DR</creatorcontrib><creatorcontrib>SIMIG GYULA DR</creatorcontrib><creatorcontrib>VAGO PAL DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BARTHA FERENC</au><au>KIRALY IMRE</au><au>NAGY KALMAN DR</au><au>MEZEI TIBOR DR</au><au>RUZSICS GYOERGY</au><au>BARKOCZY JOZSEF</au><au>VOLK BALAZS</au><au>KARASZ ADRIENN</au><au>TOEMPE PETER DR</au><au>SIMIG GYULA DR</au><au>VAGO PAL DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROCESS FOR PRODUCING ROSUVASTATIN SALT</title><date>2009-05-28</date><risdate>2009</risdate><abstract>The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial scale in high purity. The compound of the Formula (I) can be used for the treatment of diseases related to lipid metabolism.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; hun |
recordid | cdi_epo_espacenet_HUP0700667A2 |
source | esp@cenet |
title | PROCESS FOR PRODUCING ROSUVASTATIN SALT |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T23%3A49%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BARTHA%20FERENC&rft.date=2009-05-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUP0700667A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |